Back to discover
Drug

alpha-Tocopherol

In clinical development
Emerging researchLate-stage development
Also known as Carni Q-Gel Forte, D-alpha-tocopherol, Folpace Rx, Infuvite+17 more

Carni Q-Gel Forte, D-alpha-tocopherol, Folpace Rx, Infuvite, Infuvite Pediatric, Natafort, Natelle, PreNexa, Vital E- 500, Vital E- A + D3, Vital E- Newborn, Vital E- Repro, Vitamin E (Alpha Tocopherol), Vitamin E (D-Alpha Tocopherol)(Natural), d-alpha tocopherol, vitamin E (as d-alpha tocopherol), vitamin E (d-alpha tocopherol), .ALPHA.-TOCOPHEROL, .ALPHA.-TOCOPHEROL, D-, ALPHA-TOCOPHEROL, D-, alpha tocopherol.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Clinical trial2022-05-03Completed · ClinicalTrials.gov

Multicenter Vitamin E Trial in Aging Persons With Down Syndrome

Clinical trial2010-04-01Completed · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
alpha-Tocopherol
Aliases & brands
Carni Q-Gel ForteD-alpha-tocopherolFolpace RxInfuviteInfuvite PediatricNatafortNatellePreNexaVital E- 500Vital E- A + D3Vital E- NewbornVital E- ReproVitamin E (Alpha Tocopherol)Vitamin E (D-Alpha Tocopherol)(Natural)d-alpha tocopherolvitamin E (as d-alpha tocopherol)vitamin E (d-alpha tocopherol).ALPHA.-TOCOPHEROL.ALPHA.-TOCOPHEROL, D-ALPHA-TOCOPHEROL, D-alpha tocopherol
RxNorm CUI
237099
ChEMBL ID
CHEMBL3989727
ATC codes
A11HA03
UNII
H4N855PNZ1

Clinical trials

7 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
7
registered trials across all phases
LATEST COMPLETION 2025
3
Late-stage (III+)
5
Completed
2
Discontinued
PHASE DISTRIBUTIONn = 7
Early Phase 11Phase 11Phase 22Phase 32Phase N / A1

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes2
Adjuvants, Immunologic1Immunogenicity, Vaccine1
Journals, researchers & institutions
Top journals
  • Vaccine1
Leading researchers
  • Chu L1
  • Collins H1
  • Drame M1
  • Frenette L1
  • Friel D1
  • Innis BL1
  • Madan A1
  • Schuind A1
Leading institutions
free-text, unnormalised
  • 1250 South Collegeville Road1
  • Clinical Research Inc.1

Related drugs

3 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as alpha-Tocopherol in the shared literature.

1 shared disease1 shared paper

Studied across the same disease area as alpha-Tocopherol in the shared literature.

1 shared disease1 shared paper

Studied across the same disease area as alpha-Tocopherol in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials